Researchers have found a way to rebuild damaged nerve coverings that cause Multiple Sclerosis.

Researchers successfully used a synthetic compound to stimulate a receptor pathway to promote remyelination in the brain. The technique may have significant beneficial implications for treating multiple sclerosis, researchers say.